Treatment indications and thresholds of intervention: consensus and controversies in osteoporosis

References

• Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med. 1997;103(2A):12S–17S. discussion 17S.
   PubMedGoogle Scholar
• Abrahamsen B, van Staa T, Ariely R, et al. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633–1650.
   PubMed Web of Science ®Google Scholar
• Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513–521.
   PubMed Web of Science ®Google Scholar
• Liu J, Curtis EM, Cooper C, et al. State of the art in osteoporosis risk assessment and treatment. J Endocrinol Invest. 2019;42(10):1149–1164.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Odén A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239–2256.
   PubMed Web of Science ®Google Scholar
• Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22(3):465–475.
   PubMed Web of Science ®Google Scholar
• Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1–2):136.
   PubMed Web of Science ®Google Scholar
• Tosteson ANA, Melton LJ, Dawson-Hughes B, et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19(4):437–447.
   PubMed Web of Science ®Google Scholar
• Chandran M, Ganesan G, Tan KB, et al. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women. Osteoporos Int. 2021;32(1):133–144.
   PubMed Web of Science ®Google Scholar
• Chandran M, Ganesan G, Tan KB, et al. Using health-economic evidence to support policy-level decision-making in Singapore-sensitivity analysis that provides further confidence in fracture probability-based cost-effective intervention thresholds. Osteoporos Int. 2021;32(4):787–789.
   PubMed Web of Science ®Google Scholar
• Lippuner K, Johansson H, Borgström F, et al. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int. 2012;23(11):2579–2589.
   PubMed Web of Science ®Google Scholar
• Chandran M, Mitchell PJ, Amphansap T, et al. Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region. Osteoporos Int. 2021;32(7):1249–1275.
   PubMed Web of Science ®Google Scholar
• Chandran M, Bhadada SK, Ebeling PR, et al. IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific. Osteoporos Int. 2020;31(11):2077–2081.
   PubMed Web of Science ®Google Scholar
• Lobstein J. Traité d’anatomie pathologique. Livre II. F.G. Levrault, Strasbourg; 1820.
   Google Scholar
• Schapira D, Schapira C. Osteoporosis: the evolution of a scientific term. Osteoporos Int. 1992;2(4):164–167.
   PubMed Web of Science ®Google Scholar
• Mazess RB. Bone measurement in osteoporosis. Ann Intern Med. 1986;105(4):628–629.
   PubMed Web of Science ®Google Scholar
• Melton LJ, Wahner HW. Defining osteoporosis. Calcif Tissue Int. 1989;45(5):263–264.
   PubMed Web of Science ®Google Scholar
• Nordin BE. The definition and diagnosis of osteoporosis. Calcif Tissue Int. 1987;40(2):57–58.
   PubMed Web of Science ®Google Scholar
• Consensus development conference: prophylaxis and treatment of osteoporosis. JAMA. 1991;90:107–110.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Harvey NC, et al. A brief history of FRAX. Arch Osteoporos. 2018;13(1):298.
   Web of Science ®Google Scholar
• Writing Group for the ISCD Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom. 2004;7(1):17–26.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton LJ, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–1141.
   PubMed Web of Science ®Google Scholar
• Liberman UA, Weiss SR, Bröll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333(22):1437–1443.
   PubMed Web of Science ®Google Scholar
• Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280(24):2077–2082.
   PubMed Web of Science ®Google Scholar
• Ross PD, Davis JW, Epstein RS, et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114(11):919–923.
   PubMed Web of Science ®Google Scholar
• Melton LJ, Atkinson EJ, O'Fallon WM, et al. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res. 1993;8(10):1227–1233.
   PubMed Web of Science ®Google Scholar
• Jacques RM, Boonen S, Cosman F, et al. Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2012;27(8):1627–1634.
   PubMed Web of Science ®Google Scholar
• Bruyere O, Roux C, Detilleux J, et al. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab. 2007;92(8):3076–3081.
   PubMed Web of Science ®Google Scholar
• Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756–765.
   PubMed Web of Science ®Google Scholar
• Chen P, Miller PD, Delmas PD, et al. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis. J Bone Miner Res. 2006;21(11):1785–1790.
   PubMed Web of Science ®Google Scholar
• Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–475.
   PubMed Web of Science ®Google Scholar
• Chandran M. Fracture risk assessment in clinical practice: why do it? What to do it with? J Clin Densitom. 2017;20(3):274–279.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Harvey NC, Cooper C, et al. A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11(1):25.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Compston J, Cooper C, et al. SIGN guidelines for Scotland: BMD versus FRAX versus QFracture. Calcif Tissue Int. 2016;98(5):417–425.
   PubMed Web of Science ®Google Scholar
• Nguyen TV. Individualized fracture risk assessment: state-of-the-art and room for improvement. Osteoporos Sarcopenia. 2018;4(1):2–10.
   PubMedGoogle Scholar
• Kanis JA, Harvey NC, Johansson H, et al. A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res. 2020;32(2):187–196.
   PubMed Web of Science ®Google Scholar
• Johansson H, Azizieh F, Al Ali N, et al. FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int. 2017;28(11):3099–3105.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone. 2000;27(5):585–590.
   PubMed Web of Science ®Google Scholar
• Cranney A, Jamal SA, Tsang JF, et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007;177(6):575–580.
   PubMed Web of Science ®Google Scholar
• Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254–1259.
   PubMed Web of Science ®Google Scholar
• Kanis JA, McCloskey EV, Harvey NC, et al. Intervention thresholds and the diagnosis of osteoporosis. J Bone Miner Res. 2015;30(10):1747–1753.
   PubMed Web of Science ®Google Scholar
• Chakhtoura M, Leslie WD, McClung M, et al. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos Int. 2017;28(1):127–137.
   PubMed Web of Science ®Google Scholar
• Appropriate care guide: osteoporosis identification and management in primary care. Ministry of Health, Singapore [Internet]. 2018 Nov 7 [cited 2021 Jun 22]. Available from: https://www.ace-hta.gov.sg/healthcare-professionals/ace-clinical-guidances-(acgs)/details/osteoporosis-identification-and-management-in-primary-care.
   Google Scholar
• Hans D, Shevroja E, Lamy O. Use of Trabecular Bone Score as a complementary approach to DXA for fracture risk assessment in clinical practice. Rev Med Suisse. 2017;13(559):844–850.
   PubMedGoogle Scholar
• Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033–1046.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ. 2009;339:b4229.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Harvey NC, et al. A brief history of FRAX. Arch Osteoporos. 2018;13(1):118.
   PubMed Web of Science ®Google Scholar
• Nguyen ND, Frost SA, Center JR, et al. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int. 2008;19(10):1431–1444.
   PubMed Web of Science ®Google Scholar
• Dagan N, Cohen-Stavi C, Leventer-Roberts M, et al. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study. BMJ. 2017;356:i6755.
   PubMedGoogle Scholar
• Langsetmo L, Nguyen TV, Nguyen ND, et al. Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture. CMAJ. 2011;183(2):E107–E114.
   PubMed Web of Science ®Google Scholar
• Ahmed LA, Nguyen ND, Bjørnerem Å, et al. External validation of the Garvan nomograms for predicting absolute fracture risk: the Tromsø study. PloS One. 2014;9(9):e107695.
   PubMed Web of Science ®Google Scholar
• Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381.
   PubMed Web of Science ®Google Scholar
• Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract. 2020;26(Suppl 1):1–46.
   PubMed Web of Science ®Google Scholar
• Marques A, Lourenço Ó, Ortsäter G, et al. Cost-effectiveness of intervention thresholds for the treatment of osteoporosis based on FRAX(®) in Portugal. Calcif Tissue Int. 2016;99(2):131–141.
   PubMed Web of Science ®Google Scholar
• Compston J, Bowring C, Cooper A, et al. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas. 2013;75(4):392–396.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Chandran M, Chionh SB, et al. Use of age-dependent FRAX-based intervention thresholds for Singapore. Arch Osteoporos. 2020;15(1):104.
   PubMed Web of Science ®Google Scholar
• Clark P, Denova-Gutiérrez E, Zerbini C, et al. FRAX-based intervention and assessment thresholds in seven Latin American countries. Osteoporos Int. 2018;29(3):707–715.
   PubMed Web of Science ®Google Scholar
• Chandran M, McCloskey EV, Thu WPP, et al. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos. 2018;13(1):130.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3–44.
   PubMed Web of Science ®Google Scholar
• McCloskey E, Kanis JA, Johansson H, et al. FRAX-based assessment and intervention thresholds-an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int. 2015;26(8):2091–2099.
   PubMed Web of Science ®Google Scholar
• Merlijn T, Swart KMA, van der Horst HE, et al. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis. Osteoporos Int. 2020;31(2):251–257.
   PubMed Web of Science ®Google Scholar
• Söreskog E, Borgström F, Shepstone L, et al. Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Osteoporos Int. 2020;31(8):1499–1506.
   PubMed Web of Science ®Google Scholar
• Pinedo-Villanueva R, Charokopou M, Toth E, et al. Imminent fracture risk assessments in the UK FLS setting: implications and challenges. Arch Osteoporos. 2019;14(1):12.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375–382.
   PubMed Web of Science ®Google Scholar
• Center JR, Bliuc D, Nguyen TV, et al. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007;297(4):387–394.
   PubMed Web of Science ®Google Scholar
• Gehlbach S, Saag KG, Adachi JD, et al. Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2012;27(3):645–653.
   PubMed Web of Science ®Google Scholar
• Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15(4):721–739.
   PubMed Web of Science ®Google Scholar
• Briggs AM, Greig AM, Wark JD. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int. 2007;18(5):575–584.
   PubMed Web of Science ®Google Scholar
• Cooper C, Atkinson EJ, O'Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res. 1992;7(2):221–227.
   PubMed Web of Science ®Google Scholar
• Johansson L, Sundh D, Magnusson P, et al. Grade 1 vertebral fractures identified by densitometric lateral spine imaging predict incident major osteoporotic fracture independently of clinical risk factors and bone mineral density in older women. J Bone Miner Res. 2020;35(10):1942–1951.
   PubMed Web of Science ®Google Scholar
• Lentle BC, Berger C, Probyn L, et al. Comparative analysis of the radiology of osteoporotic vertebral fractures in women and men: cross-sectional and longitudinal observations from the Canadian Multicentre Osteoporosis Study (CaMos). J Bone Miner Res. 2018;33(4):569–579.
   PubMed Web of Science ®Google Scholar
• Lems WF, Paccou J, Zhang J, et al. Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporos Int. 2021;32(3):399–411.
   PubMed Web of Science ®Google Scholar
• Balasubramanian A, Zhang J, Chen L, et al. Risk of subsequent fracture after prior fracture among older women. Osteoporos Int. 2019;30(1):79–92.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Harvey NC, McCloskey E, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31(1):1–12.
   PubMed Web of Science ®Google Scholar
• Shoback D, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society Guideline Update. J Clin Endocrinol Metab. 2020;105(3):dgaa048.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Lippuner K, Lamy O, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Med Wkly. 2020;150:w20352.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Rizzoli R, Cooper C, et al. Challenges for the development of bone-forming agents in Europe. Calcif Tissue Int. 2014;94(5):469–473.
   PubMed Web of Science ®Google Scholar